Considerations in the Pediatric Population with Cancer

Dental Clinics of North America

Volumn 52, Issue 1, 2008, Pages 155-181

  Hong, Catherine H ^a   daFonseca, Marcio ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BLOOD; CHILD; DENTAL CARE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INSTRUMENTATION; MALE; METHODOLOGY; MICROBIOLOGY; MOUTH DISEASE; MOUTH HYGIENE; NEOPLASM; RADIATION INJURY; RADIOTHERAPY; REVIEW; STANDARD; STOMATITIS; TOOTH MALFORMATION; VIROLOGY;

ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; CHILD; DENTAL CARE FOR CHILDREN; DENTAL CARE FOR CHRONICALLY ILL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MOUTH DISEASES; NEOPLASMS; ORAL HYGIENE; RADIATION INJURIES; RADIOTHERAPY; STOMATITIS; TOOTH ABNORMALITIES;

EID: 37249085580     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2007.10.001     Document Type: Review

References (124)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 57 1 (2007) 43-66
2. Berkowitz R.J., Strandjord S., Jones P., et al. Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatr Dent 9 2 (1987) 105-110
3. Childers N.K., Stinnett E.A., Wheeler P., et al. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 75 1 (1993) 41-47
4. Dahlloff G., Heimdahl A., Bolme P., et al. Oral condition in children treated with bone marrow transplantation. Bone Marrow Transplantation 3 1 (1988) 43-51
5. Fayle S.A., and Curzon M.E. Oral complications in pediatric oncology patients. Pediatr Dent 13 5 (1991) 289-295
6. Kamp A.A. Neoplastic diseases in a pediatric population: a survey of the incidence of oral complications. Pediatr Dent 10 1 (1988) 25-29
7. Sonis A., and Sonis S. Oral complications of cancer chemotherapy in pediatric patients. J Pedod 3 2 (1979) 122-128
8. Niehaus C.S., Meiller T.F., Peterson D.E., et al. Oral complications in children during cancer therapy. Cancer Nurs 10 1 (1987) 15-20
9. Weisman S.J., Scoopo F.J., Johnson G.M., et al. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol 8 3 (1990) 453-459
10. Graber C.J., de Almeida K.N., Atkinson J.C., et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27 5 (2001) 537-542
11. Greenberg M.S., Cohen S.G., McKitrick J.C., et al. The oral flora as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 53 1 (1982) 32-36
12. Lark R.L., McNeil S.A., VanderHyde K., et al. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 33 3 (2001) 338-343
13. Marron A., Carratala J., Gonzalez-Barca E., et al. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 31 5 (2000) 1126-1130
14. Stevenson-Moore P. Oral complications of cancer therapies. Essential aspects of a pretreatment oral examination. NCI Monogr 9 (1990) 33-36
15. Brennan M.T., von Bultzingslowen I., Schubert M.M., et al. Alimentary mucositis: putting the guidelines into practice. Support Care Cancer 14 6 (2006) 573-579
16. Barker G.J. Current practices in the oral management of the patients undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 7 1 (1999) 17-20
17. da Fonseca M.A. Dental care of the pediatric cancer patient. Pediatr Dent 26 1 (2004) 53-57
18. Peterson D.E., and Overholser D.C. Increased morbidity associated with oral infection in patients with acute nonlymphocytic leukemia. Oral Surg Oral Med Oral Pathol 51 4 (1981) 390-393
19. Gibson F. Best practice in oral care for children and young people being treated for cancer: can we achieve consensus?. European J Cancer 40 8 (2004) 1109-1110
20. Glenny A.M., Gibson F., Auld E., et al. A survey of current practice with regard to oral care for children being treated for cancer. Eur J Cancer 40 8 (2004) 1217-1224
21. Loh A., O'Hoy P., Tran X., et al. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent 26 5 (2004) 401-409
22. Ibricevic H., and al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. J Clin Pediatr Dent 24 4 (2000) 269-272
23. Peters E., Monopoli M., Woo S.B., et al. Assessment of the need for treatment of postendodontic asymptomatic periapical radiolucencies in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 76 1 (1993) 45-48
24. Raber-Durlacher J.E., Epstein J.B., Raber J., et al. Periodontal infection in cancer patients treated with high dose chemotherapy. Support Care Cancer 10 6 (2002) 466-473
25. Peterson D.E. Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 9 (1990) 61-71
26. Sheller B., and Williams S. Orthodontic management of patients with hematologic malignancies. AM J Orthod Dentofac Orthop 109 6 (1996) 575-580
27. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 108 (2003) 2015-2031
28. Lockhart P.B., Brennen M.T., Fox P.C., et al. Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis 34 12 (2002) 1621-1626
29. Lockhart P.B., Loven B., Brennan M.T., et al. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. J Am Dent Assoc 138 4 (2007) 458-474
30. National Cancer Institute website. Oral complications of chemotherapy and head/neck radiation. Available at: http://www.cancer.gov/cancertopics/pdq/supportivecare/oralcomplications/healthprofessional.
31. American Academy of Pediatric Dentistry Clinical Affairs Committee; American Academy of Pediatric Dentistry Council on Clinical Affairs. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent 27 7 Reference Manual (2005-2006) 170-175
32. Teruya J. Indications for red cell transfusion in infants and children. Available at: www.Uptodate.com. Accessed May 10, 2007.
33. Roseff S.D., Luban N.L., and Manno C.S. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42 11 (2002) 1398-1413
34. Carson J.L., Duff A., Berlin J.A., et al. Perioperative blood transfusion and postoperative mortality. JAMA 279 3 (1998) 199-205
35. Schiffer C.A., Anderson K.C., Bennett C.L., et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 5 (2001) 1519-1538
36. McGuire D.B., Correa M.E.P., Johnson J., et al. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14 6 (2006) 541-547
37. Borowski B., Benhamou E., Pico J.L., et al. Prevention of oral mucositis in patients treated with high dose chemotherapy and bone marrow transplantation. A randomized controlled trial comparing 2 protocols of dental care. Eur J Cancer B Oral Oncol 30B 2 (1994) 93-97
38. Kennedy H.F., Morrison D., Tomlinson D., et al. Gingivitis and toothbrushes: potential roles in viridans streptococcal bacteraemia. J Infect 46 1 (2003) 67-70
39. Addems A., Epstein J.B., Damji S., et al. The lack of efficacy of a foam brush in maintaining gingival health: a controlled study. Spec Care Dentist 12 3 (1992) 103-106
40. Ransier A., Epstein J.B., Lunn R., et al. A combined analysis of a toothbrush, foam brush and a chlorhexidine-soaked foam brush in maintaining oral hygiene. Canc Nurs 18 5 (1995) 393-396
41. Bellm L.A., Epstein J.B., Rose-Ped A., et al. Patient reports of complications of bone marrow transplantation. Support Care Cancer 8 1 (2000) 33-39
42. Hedstrom M., Haglund K., Skolin I., et al. Distressing events for children and adolescents with cancer: child, parent and nurse perceptions. J Pediatr Oncol Nurs 20 3 (2003) 120-132
43. Sonis S.T., Oster G., Fuchs H., et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol 19 8 (2001) 2201-2205
44. Murray J.C., Chiu J.K., Dorfman S.R., et al. Epiglottitis following preparation for allogeneic bone marrow transplantation. Bone Marrow Transplant 15 6 (1995) 997-998
45. Sonis S.T., Elting L.S., Keefe D., et al. Perspectives on cancer therapy-induced mucosal injury. pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 9 Suppl (2004) 1995-2025
46. Jaroneski L.A. The importance of assessment rating scales for chemotherapy-induced oral mucositis. Oncol Nurs Forum 33 6 (2006) 1085-1090
47. Barasch A., and Peterson D.E. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39 2 (2003) 91-100
48. Rapoport A.P., Miller Watelet L.F., Linder T., et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem cell transplants. J Clin Oncol 17 8 (1999) 2446-2453
49. Robien K., Schubert M.M., Bruemmer B., et al. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22 7 (2004) 1268-1275
50. Michelet M., Desmery P., Juni M., et al. Prognostic factors for high dose chemotherapy-induced oral mucositis with autologous peripheral blood stem-cell transplant: a single institutional experience. [Abstract #76]. Supportive Care in Cancer 12 (2004) 390 MASCC/ISOO 16th International Symposium Supportive Care in Cancer
51. Wardley A.M., Jayson G.C., Swindell R., et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematology 110 2 (2000) 292-299
52. Raber-Durlacher J.E., Weiji N.I., Abu Saris M., et al. Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 8 5 (2000) 366-371
53. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351 25 (2004) 2590-2598
54. New biotechnology drug approved to treat mucositis associated with cancer treatments. Available at: http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01332.htm.
55. Barasch A., Elad S., Altman A., et al. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 14 6 (2006) 528-532
56. Migliorati C.A., Oberle-Edwards L., and Schubert M. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis. Support Care Cancer 14 6 (2006) 533-540
57. Keefe D.M., Schubert M.M., Elting L.S., et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109 (2007) 820-831
58. Levy-Polack M.P., Sebelli P., and Polack N.L. Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care in Dent 18 5 (1998) 189-193
59. Bonnaure-Mallet M., Bunetel L., Tricot-Doleux S., et al. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 34 10 (1990) 1588-1591
60. Belfield P.M., and Dwyer A.A. Oral complications of childhood cancer and its treatment: current best practice. Eur J Cancer 40 7 (2004) 1035-1041
61. DiNubile M.J., Hille D., Sable C.A., et al. Invasive candidiasis in cancer patients: observations from a randomized clinical trial. J Infect 50 5 (2005) 443-449
62. Grigull L., Beier R., Schrauder A., et al. Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 46 11-12 (2003) 441-446
63. Rex J.H., Walsh T.J., Sobel J.D., et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 30 4 (2000) 662-678
64. Clarkson J.E., Worthington H.V., and Eden O.B. Interventions for preventing oral candidiasis forpatients with cancer receiving treatment. Cochrane Database Syst Rev 1 (2007 Jan 24) CD003807
65. Gøtzsche P.C., and Johansen H.K. Nystatin prophylaxis and treatment inseverely immunodepressed patients. Cochrane Database Syst Rev 2 (2002) CD002033. Update in: Cochrane Database Syst Rev 2002;(4):CD002033
66. Worthington H.V., Clarkson J.E., and Eden O.B. Interventions for treating oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2 (2007) CD001972
67. Kinirons M.J., Fleming P., and Boyd D. Dental caries of children in remission from acute lymphoblastic leukaemia in relation to the duration of treatment and the period of time in remission. Int J Paediatr Dent 5 3 (1995) 169-172
68. Redding S.W. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis. NCI Monogr 9 (1990) 103-105
69. Schubert M.M., Peterson D.E., Flournoy, et al. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. Oral Surg Oral Med Oral Pathol 70 3 (1990) 286-293
70. Carrega G., Castagnola E., Canessa A., et al. Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer 2 4 (1994) 266-269
71. Wade J.C., Newton B., Flournoy N., et al. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplant. Ann Intern Med 100 6 (1984) 823-828
72. Dreizen S., McCredie K.B., and Keating M.J. Chemotherapy-associated oral hemorrhages in adults with leukemia. Oral Surg Oral Med Oral Pathol 57 5 (1984) 494-498
73. Wahlin Y.B., and Matsson L. Oral mucosal lesions in patients with acute leukemia and related disorders during cytotoxic therapy. Scand J Dent Res 96 2 (1988) 128-136
74. Garfunkel A.A., Galili D., Findler M., et al. Bleeding tendency: a practical approach in dentistry. Compend Contin Educ Dent 20 9 (1999) 836-838
75. Nieuw Amerongen A.V., and Veerman E.C. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11 4 (2003) 226-231
76. Mackie A.M., Coda B.C., and Hill H.F. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 46 3 (1991) 265-269
77. Rubenstein E.B., Peterson D.E., Schubert M.M., et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 9 Suppl (2004) 2026-2046
78. Kennedy L., and Diamond J. Assessment and management of chemotherapy-induced mucositis in children. J Pediatr Oncol Nursing 14 3 (1997) 164-174
79. Skolin I., Wahlin Y.B., Broman D.A., et al. Altered food intake and taste perception in children with cancer after start of chemotherapy: perspectives of children, parents and nurses. Support Care Cancer 14 4 (2006) 369-378
80. Vissink A., Jansma J., Spijkervet F.K., et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14 3 (2003) 199-212
81. McCarthy G.M., and Skillings J.R. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol 74 3 (1992) 299-304
82. Vissink A., Burlage F.R., Spijkervet K.F., et al. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14 3 (2003) 213-225
83. Dikjstra P.U., Kalk W.W., and Roodenburg J.L. Trismus in head and neck oncology: a systematic review. Oral Oncol 40 9 (2004) 879-889
84. Kaste S.C., Hopkins K.P., and Bowman L.C. Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma. Med Pediatr Oncol 25 2 (1995) 96-101
85. Fromm M., Littman P., Raney R.B., et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer 57 10 (1986) 2070-2076
86. Fleming P., and Kinirons M.J. Study of the dental health of children in remission from acute lymphoblastic leukaemia in Northern Ireland. Community Dent Oral Epidemiol 21 5 (1993) 309-312
87. Goho C. Chemoradiation therapy: effect on dental development. Pediatr Dent 15 1 (1993) 6-12
88. Karadzov O.M., Sedlecki-Gvozdenovic S.D., Demajo M., et al. The effects of x-ray irradiation of the head region of eight-day-old rats on the development of molar and incisor teeth. Strahlentherapie 161 7 (1985) 448-452
89. Dahllof G., Nasman M., Borgstrom A., et al. Effect of chemotherapy on dental maturity in children with hematological malignancies. Pediatr Dent 11 4 (1989) 303-306
90. Alpaslan G., Alpaslan C., Gogen H., et al. Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 3 (1999) 317-321
91. Nasman M., Forsberg C.M., and Dahlloff G. Long term dental development in children after treatment for malignant disease. Eur J Orthd 19 2 (1997) 151-159
92. Holtta P., Hovi L., Saarinen-Pihkala U.M., et al. Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT. Cancer 103 7 (2005) 4184-4193
93. Holtta P., Alaluusua S., Saarinen-Pihkala U.M., et al. Long term adverse effects on dentition in children with poor-risk neuroblastoma treated with high dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone marrow transplant 29 2 (2002) 121-127
94. Karsila-Tenovuo S., Jahnukainen K., Peltomaki T., et al. Disturbances in craniofacial morphology in children treated for solid tumors. Oral Oncol 37 7 (2001) 586-592
95. Sonis A.L., Tarbell N., Valachovic R.W., et al. Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities. Cancer 66 12 (1990) 2645-2652
96. Raney R.B., Asmar L., and Vassilopoulou-Sellin R. Late complications of therapy in 213 children with localized, nonorbital soft tissue sarcoma of the head and neck: a descriptive report from the intergroup rhabdomyosarcoma studies (IRS)-II and -III. Med Pediatr Oncol 33 4 (1999) 362-371
97. Dahllof G., Bagesund M., and Ringden O. Impact of conditioning regimens on salivary function, caries associated microorganisms and dental caries in children after bone marrow transplantation. A 4 year longitudinal study. Bone Marrow Transplant 20 6 (1997) 479-483
98. Dahllof G., Bagesund M., Remberger M., et al. Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation. Oral Oncol 33 5 (1997) 327-331
99. Schuchter L.M., Hensley M.L., Meropol N.J., et al. 2002 Update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 20 12 (2002) 2895-2903
100. Sanders J.E. Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Amer 44 (1997) 1005-1020
101. Woo S.-B., Lee S.J., and Schubert M.M. Graft-vs-host disease. Crit Rev Oral Biol Med 8 (1997) 201-216
102. Higman M.A., and Vogelsang G.B. Chronic graft versus host disease. Br J Haematol 125 (2004) 435-454
103. Horwitz M.E., and Sullivan K.M. Chronic graft-versus-host disease. Blood Rev 20 (2006) 15-27
104. Hsiao M., Schubert M., Thornquist M., et al. Oral manifestations of acute graft vs host disease (A-GVHD) following marrow transplantation. J Dent Res 67 (1988) 202
105. Treister N.S., Woo S.-B., O'Holleran E.W., et al. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Bone Marrow Transplant 11 (2005) 721-731
106. Nakamura S., Hiroki A., Shinohara M., et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Radiol Endod 82 (1996) 556-563
107. Scaradavou A., Heller G., Sklar C.A., et al. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 76 10 (1995) 1860-1867
108. Cohen R.J., Curtis R.E., Inskip P.D., et al. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 103 11 (2005) 2391-2396
109. Curtis R.E., Metayer C., Rizzo J.D., et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 105 (2005) 3802-3811
110. Maguire A., Craft A.W., Evans R.G.B., et al. The long term effects of treatment on the dental condition of children surviving malignant disease. Cancer 60 10 (1987) 2570-2575
111. Nasman M., Bjork O., Soderhall S., et al. Disturbances in the oral cavity in pediatric long term survivors after different forms of antineoplastic therapy. Pediatr Dent 16 3 (1994) 217-223
112. Alberth M., Kovalecz G., Nemes J., et al. Oral health of long term childhood cancer survivors. Pediatr Blood Cancer 43 1 (2004) 88-90
113. Pajari U., Larmas M., and Lanning M. Caries incidence and prevalence in children receiving antineoplastic therapy. Caries Res 22 5 (1988) 318-320
114. Schubert M.M., Sullivan K.M., and Truelove E.L. Head and neck complications of bone marrow transplantation. In: Peterson D.E., Elias E.G., and Sonis S.T. (Eds). Head and neck management of the cancer patient (1986), Martinus Nijhoff Pub, Boston 401-427
115. Schubert M.M., Sullivan K.M., Isutzu K.T., et al. Oral complications of bone marrow transplantation. In: Peterson D.E., and Sonis S.T. (Eds). Oral complications of cancer chemotherapy (1983), Martinus Nijhoff Pub, Boston 93-112
116. Schubert M.M., Peterson D.E., and Lloid M.E. Oral complications. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Hematopoietic cell transplantation. 2nd edition (1999), Blackwell Science, Malden (MA) 751-763
117. Gibson N., and Ferguson J.W. Steroid cover for dental patients on long-term steroid medication: proposed clinical guidelines based upon a critical review of the literature. Br Dent J 197 11 (2004) 681-685
118. Epstein J., Rea G., Wong F.L., et al. Osteoradionecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10 1 (1987) 48-54
119. O'Sullivan B.P., Oatis Jr. G.W., and Grisius R.J. Osteoradionecrosis: its prevention. Clin Prev Dent 4 4 (1982) 8-12
120. Ashamalla H.L., Thom S.R., and Goldwein J.W. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children. The University of Pennsylvania experience. Cancer 77 11 (1996) 2407-2412
121. Annane D., Depondt J., Aubert P., et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 22 24 (2004) 4893-4900
122. Marx R.E. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 41 6 (1983) 351-357
123. Dahllof G., Jonsson A., Ulmmer M., et al. Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation. Am J Orthod Dentofacial Orthop 120 5 (2001) 459-465
124. Shaw L., and Glenwright H.D. The role of medications in dental caries formation: need for sugar-free medication for children. Pediatrician 16 3-4 (1989) 153-155